drugset / Trial / NCT07860710
J-LINX: Japan LINerixibat eXtension Study
NaSingle-groupOpen-labelTreatment
Summary
This study evaluates the long-term safety and tolerability of linerixibat in Japanese adults with cholestatic pruritus in primary biliary cholangitis (PBC) who previously participated in the linerixibat long-term safety and efficacy study, LLSAT (NCT04167358). Participants will continue receiving linerixibat while researchers monitor adverse events and other safety measures to better understand the long-term safety of treatment and provide continued access to therapy.
Timeline
- Start
- 2026-10-09
- Primary completion
- 2028-10-23
- Completion
- 2028-10-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Linerixibat | Small molecule | — | — |
Indications
No indication recorded.